A SCALABLE SOLUTION FOR NEXT-GENERATION RNA TECHNOLOGY & DELIVERY

CAR T Cell Therapy with a Scalable RNA Lipid Nanoparticle PlatformПодробнее

Next-generation Approaches for Rapid Production of Nanoparticles for Use in Gene and Cell TherapiesПодробнее

Translating mRNA-Based Medicines from Concept to ClinicПодробнее

Optimized and scalable LNP composition for RNA vaccine deliveryПодробнее

Navigate CGT Success: Align cGMP Gene Editing with Regulatory FrameworksПодробнее

Next Generation of mRNA VaccinologyПодробнее

Technologies Addressing Stability & Delivery for mRNA Therapies/VaccinesПодробнее

RNA-Lipid Nanoparticle Platform for the Multi-step engineering of gene edited CAR-T cells.Подробнее

A SCALABLE SOLUTION FOR NEXT-GENERATION RNA TECHNOLOGY & DELIVERYПодробнее

A Scalable Solution for Large Scale Manufacturing of Vaccine Adjuvants and Delivery SystemsПодробнее

"Ionizable lipid nanoparticles advance translation of mRNA-based vaccines & therapy” - Gairdner WeekПодробнее

Microfluidizer® Technology for Producing RNA Delivery Platforms | Presented by Dr. Yang SuПодробнее

Non-viral Delivery: Where Can New Platforms Take Genetic Medicines?Подробнее

Developing Scalable RNA-LNP Drug Products for Clinical ReadinessПодробнее

Microfluidics Lipid Nanoparticles for next generation RNA/DNA DeliveryПодробнее

Manufacturing RNA lipid nanoparticles to deliver high quality transformative medicinesПодробнее

Yaniv Erlich on building a scalable platform to discover next-gen RNA therapeuticsПодробнее

Next-Generation RNA Vaccines & TherapiesПодробнее

Optimized and Scalable LNP Composition for RNA Vaccine DeliveryПодробнее

Accelerating UK innovation to develop next-generation therapeuticsПодробнее